1995年5月,邹卫民同志论文证书...........
全国中医痛症学术研讨会证书
获得郑州市优秀学术论文证书
患者赠送锦旗
                   
  根据仅保存的社会各医院及各单位邀请会诊治疗血液病的信函、会诊单统计如下:
   1978年3月参加郑州"西学中"第二期,任教师,主讲《伤寒论》,得到上级卫生部门的好评。学生来自各医院单位的医师。
   1978年2月8日参加中华医学会河南分会血液研究学术会议,写有血液病论文......

地址:中原区桐柏南路万福花园34号楼
邮编:450053
联系电话:15838168106 0371-63922979(传真)
联系人:邹卫民
电子信箱:zwmnet@163.com
 

 Item Introduction
【YI XUE NING】【JIANG BAI oral liquid】【LIU XIAO AN capsule】
The specification of the drugs patent item to be developmented

    Currently, the hemopathy drugs has great potential development. The chemical examination diagnosis is effective, but therapeutics is not ideal.
    Zou Weimin and his father, the old Chinese traditional doctor has drne rescarch in this fiela. A patient examined with the Western medical wag, and treated with the traditional Chinese medicine is effective in the clinic Take medicine for 30 days as a course of treatment and have a blood routine examination every 10 days, then therapeutic effect can be observed. So they has acquired the Henan province prize of science and technology. There are 3000 typical cases.
   A: the drugs development:
    (1)【YI XUE NING】 Condensed pill.
    Indication: Thrombocytopenic purpura,aplastic anemia and hemorrhage disease. This recipe is indicated for deficiency syndrome of both qi and blood due to hemophilia, leukaemia, cancer. This drug has already got the national patent (NO.200510064633.X) and health food pass number.
    (2)【JIANG BAI oral liquid】 Indication: Leukemia. This recipe is indicated for the white blood increase. This drug has already got the national patent (NO.200410050165.6).
    (3)【LIU XIAO AN capsule】 Indication: Lymphoid cell leukemia, malignant lymphoid tumor, diaphragm malignant tumor, lymphoid system tumors, such as, chest film and the proud flesh malignant tumor, etc…
    B: the forms production:
    These drugs patent item is still used for the patient with decoction. They will be manufactured with condensed pill, capsule, injection, oral liquid and granule.
    C: the cooperation intention and performance analysis:
    1.Look for the investment company or agent and pharmaceutical factory.
    2.Exploiture the new drugs. Attract bid for invite investments of 300,000 dollars to acquire the approve of the state food and drug administration of China.
    Hemopathy patient is over 8 millions according to the clinical statistic. If this product be used in clinic and 10% patients used these drugs, will have several hundred million incomes in the 3 years.
    The item related data: the possibility report and patent data can be review and download in the blood disease Web address.
    Zheng Zhou Tong Ji Tradutional Medicine Hospital
    Consult doctor:Zou weimin
    Consult hot-line:15838168106 0371-63922979(传真)
    Blood disease Web address: www.zouweimin.com

tml>